VERVE THERAPEUTICS INC (VERV) Institutional Ownership
None of the superinvestors we track currently report VERVE THERAPEUTICS INC (VERV) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in VERVE THERAPEUTICS INC (VERV), this page will show institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2025 | 1 | $11,764,548 | 1,047,600 |
| Q1 2025 | 1 | $826,256 | 180,800 |
| Q4 2024 | 1 | $2,049,576 | 363,400 |
| Q3 2024 | 1 | $2,781,964 | 574,786 |
| Q2 2024 | 2 | $16,643,547 | 3,410,563 |
| Q1 2024 | 2 | $80,220,165 | 6,239,803 |
| Q4 2023 | 2 | $97,932,404 | 7,189,683 |
| Q3 2023 | 1 | $68,959,525 | 5,200,567 |
| Q2 2023 | 1 | $96,578,455 | 5,150,851 |
| Q1 2023 | 1 | $64,631,752 | 4,482,091 |
| Q4 2022 | 1 | $84,478,811 | 4,365,830 |
| Q3 2022 | 1 | $116,579 | 3,393,859 |
Related VERV Institutional Insights:
- VERV Institutional Ownership & Insiders Activity
- VERV Institutional Ownership & 13F Activity
- VERV Top Institutional Shareholders
- VERV Institutional Buying Activity
- VERV Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- VERV Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings